Related Experiment Video
Updated: Jul 1, 2026

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis
Published on: May 12, 2020
Non-antibiotic management of bacterial keratitis
Mizna Akbar1, Christopher Phung1, Alexis Monical1
1Department of Ophthalmology and Visual Science at the University of Chicago, Chicago, IL, United States.
None:
Bacterial keratitis (BK) is a common subtype of infectious keratitis, the most common cause of corneal blindness globally. While antibiotics are the mainstay of treatment for BK, numerous nonantibiotic treatments and adjuncts have emerged in recent years. These include, but are not limited to, collagen cross-linking, phototherapy, immunomodulators, and various forms of transplantation. The purpose of this work is to provide a comprehensive summary of the current literature, highlight promising areas of progress, and identify gaps and areas for further work in the management of BK. With rising resistance to antibiotics, this review echoes and emphasizes the call to study and establish alternative and adjunctive strategies for BK treatment.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Angle Closure Glaucoma: Treatment
Tonsillitis II: Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Inhibitors of Bacterial Protein Synthesis
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
